Post-dilution hemodiafiltration with a heparin-grafted polyacrylonitrile membrane

Area of Science:

• Nephrology
• Biomaterials Science
• Clinical Medicine

Background:

• Hemodialysis requires effective anticoagulation to prevent circuit clotting.
• Heparin-grafted membranes (HeprAN) offer a potential alternative to standard anticoagulation protocols.
• Optimizing anticoagulation strategies is crucial for patient safety and treatment efficiency.

Purpose of the Study:

• To evaluate the safety and efficacy of post-dilution hemodiafiltration using a HeprAN membrane with reduced anticoagulation.
• To compare different anticoagulation regimens (unfractionated heparin, LMWH) with the HeprAN membrane.

Main Methods:

• A prospective, multicenter study involving 44 patients undergoing post-dilution on-line hemodiafiltration.
• Three consecutive treatment modalities were tested, varying membrane type and anticoagulation strategy.
• Coagulation parameters and dialyzer clotting rates were monitored.

Main Results:

• The HeprAN membrane with reduced LMWH anticoagulation showed low rates of dialyzer clotting (1-2%).
• Reduced anticoagulation with LMWH and HeprAN resulted in a favorable coagulation profile.
• Dialyzer clotting was significantly higher with unfractionated heparin and no heparin priming.

Conclusions:

• The HeprAN membrane is suitable for routine post-dilution hemodiafiltration with reduced LMWH doses.
• This approach offers a safe and effective alternative for anticoagulation in hemodialysis.
• Reduced anticoagulation strategies can be safely implemented with specialized membranes.